Supernus Pharmaceuticals
Price & Volume
Stats
See moreOpen | $45.55 |
Previous Close | $45.15 |
Day Range | $45.45-$46.75 |
52W Range | $29.16-$57.65 |
Market Cap | $2.5B |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $681.5M |
Revenue Growth (YoY) | 9.3% |
Gross Profit (12 Mos) | $605.6M |
Diluted EPS | -$0.34 |
News
See moreYahoo Finance • 4 days ago
Supernus Pharmaceuticals to Participate in the Piper Sandler 37th Annual Healthcare Conference
Yahoo Finance • 8 days ago
Why This Fund Trimmed a $161 Million Travere Position After a 100% Rally
Yahoo Finance • 20 days ago
Supernus Pharmaceuticals (SUPN) is Benefiting from Its Strength in Financial Position
Yahoo Finance • 21 days ago
Supernus Announces Third Quarter 2025 Financial Results
About
CEO | Mr. Jack A. Khattar M.B.A. |
CFO | Mr. Timothy C. Dec |
Address | 9715 Key West Avenue, Rockville, MD, United States, 20850 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 674 |
